Elicio Therapeutics, Inc. SEC filings ELTX
Elicio Therapeutics, Inc. has 384 filings in SEC EDGAR's recent list, going back to Mar 4, 2014. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| DEF 14A | Proxy statement | Oct 9, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Sep 14, 2026 | Sep 14, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 424B5 | Prospectus supplement | Jul 2, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 2, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 24, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Other events
|
Jun 17, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Other events
|
Jun 15, 2026 | Jun 15, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| 10-K/A | Amended annual report | Apr 29, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Mar 16, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Mar 16, 2026 | Mar 16, 2026 |
| 424B5 | Prospectus supplement | Mar 16, 2026 | — |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| CORRESP | Letter to the SEC | Mar 12, 2026 | — |
| S-3/A | Filing | Mar 12, 2026 | — |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| UPLOAD | Letter from the SEC | Mar 6, 2026 | — |
| S-3/A | Filing | Mar 2, 2026 | — |
| S-3 | Shelf registration | Feb 27, 2026 | — |
| EFFECT | Filing | Dec 3, 2025 | — |
| CORRESP | Letter to the SEC | Dec 1, 2025 | — |
| S-3 | Shelf registration | Nov 13, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 17, 2025 | Sep 17, 2025 |
| 8-K |
Current report
Other events
|
Aug 12, 2025 | Aug 12, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Other events
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Jun 4, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2025 | May 19, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| ARS | Annual report to shareholders | Apr 9, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 9, 2025 | Apr 9, 2025 |
| S-8 | Employee stock plan registration | Mar 31, 2025 | — |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 24, 2025 | Mar 21, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Mar 5, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 30, 2025 | Jan 29, 2025 |
| 424B5 | Prospectus supplement | Jan 30, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 23, 2025 | Jan 23, 2025 |
| 8-K |
Current report
Other events
|
Jan 22, 2025 | Jan 22, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 12, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Other events
|
Dec 3, 2024 | Dec 3, 2024 |
| 424B3 | Prospectus | Nov 22, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Nov 21, 2024 | Nov 21, 2024 |
| EFFECT | Filing | Nov 20, 2024 | — |
| CORRESP | Letter to the SEC | Nov 18, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2024 | — |
| S-3 | Shelf registration | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 17, 2024 | Oct 15, 2024 |
| ARS | Annual report to shareholders | Sep 27, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Sep 27, 2024 | Nov 7, 2024 |
| PRE 14A | Preliminary proxy statement | Sep 17, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 30, 2024 | Aug 27, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Aug 12, 2024 | Aug 12, 2024 |
| 424B5 | Prospectus supplement | Jul 1, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 1, 2024 | Jun 28, 2024 |
| 424B5 | Prospectus supplement | Jun 27, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 27, 2024 | Jun 27, 2024 |
| EFFECT | Filing | Jun 11, 2024 | — |
| EFFECT | Filing | Jun 11, 2024 | — |
| CORRESP | Letter to the SEC | Jun 10, 2024 | — |
| CORRESP | Letter to the SEC | Jun 7, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2024 | — |
| S-3 | Shelf registration | Jun 3, 2024 | — |
| CORRESP | Letter to the SEC | Jun 3, 2024 | — |
| S-3/A | Filing | Jun 3, 2024 | — |
| 8-K |
Current report
Other events
|
May 24, 2024 | May 23, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 10-K/A | Amended annual report | Apr 29, 2024 | Dec 31, 2023 |
| UPLOAD | Letter from the SEC | Apr 10, 2024 | — |
| 8-K |
Current report
Other events
|
Apr 5, 2024 | Apr 5, 2024 |
| S-8 | Employee stock plan registration | Mar 29, 2024 | — |
| S-3 | Shelf registration | Mar 29, 2024 | — |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2024 | Mar 29, 2024 |
| D | Filing | Mar 29, 2024 | — |
| 8-K |
Current report
Material agreement
|
Mar 18, 2024 | Mar 18, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 2, 2024 | Feb 1, 2024 |
| 8-K |
Current report
Other events
|
Jan 17, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Other events
|
Jan 16, 2024 | Jan 16, 2024 |
| 8-K |
Current report
Other events
|
Jan 9, 2024 | Jan 9, 2024 |
| D | Filing | Jan 5, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 22, 2023 | Dec 22, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Other events
|
Nov 3, 2023 | Nov 3, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 20, 2023 | Oct 19, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 12, 2023 | Oct 5, 2023 |
| 8-K |
Current report
Other events
|
Sep 28, 2023 | Sep 27, 2023 |
| 8-K |
Current report
Other events
|
Sep 7, 2023 | Sep 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 30, 2023 | Aug 28, 2023 |
| S-8 | Employee stock plan registration | Aug 21, 2023 | — |
| 8-K/A | Amended current report | Aug 14, 2023 | May 31, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Other events
|
Jun 5, 2023 | Jun 3, 2023 |
| 8-K |
Current report
Acquisition or sale of assets, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure, Other events
|
Jun 2, 2023 | May 31, 2023 |
| 425 | Filing | May 30, 2023 | — |
| 8-K |
Current report
Other events
|
May 30, 2023 | May 30, 2023 |
| 425 | Filing | May 24, 2023 | — |
| 8-K |
Current report
Other events
|
May 24, 2023 | May 23, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Other events
|
May 1, 2023 | May 1, 2023 |
| SEC STAFF LETTER | Filing | Apr 28, 2023 | — |
| EFFECT | Filing | Apr 28, 2023 | — |
| 10-K/A | Amended annual report | Apr 28, 2023 | Dec 31, 2022 |
| 424B3 | Prospectus | Apr 28, 2023 | — |
| 8-K |
Current report
Other events
|
Apr 27, 2023 | Apr 27, 2023 |
| S-4/A | Form s-4/a | Apr 27, 2023 | — |
| CORRESP | Letter to the SEC | Apr 26, 2023 | — |
| CORRESP | Letter to the SEC | Apr 21, 2023 | — |
| S-4/A | Form s-4/a | Apr 21, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 20, 2023 | — |
| CORRESP | Letter to the SEC | Apr 13, 2023 | — |
| S-4/A | Form s-4/a | Apr 13, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2023 | — |
| SEC STAFF LETTER | Filing | Apr 6, 2023 | — |
| CORRESP | Letter to the SEC | Mar 29, 2023 | — |
| S-4/A | Form s-4/a | Mar 29, 2023 | — |
| S-8 | Employee stock plan registration | Mar 17, 2023 | — |
| 10-K | Annual report | Mar 17, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Mar 14, 2023 | Mar 9, 2023 |
| UPLOAD | Letter from the SEC | Mar 10, 2023 | — |
| S-4 | Registration for a merger or exchange | Feb 13, 2023 | — |
| 425 | Filing | Jan 18, 2023 | — |
| 425 | Filing | Jan 18, 2023 | — |
| 425 | Filing | Jan 18, 2023 | — |
| 425 | Filing | Jan 17, 2023 | — |
| 425 | Filing | Jan 17, 2023 | — |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Jan 17, 2023 | Jan 13, 2023 |
| 8-K |
Current report
Listing notice
|
Dec 22, 2022 | Dec 15, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change
|
Jul 25, 2022 | Jul 25, 2022 |
| 8-K |
Current report
Results of operations
|
Jun 29, 2022 | Jun 29, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2022 | Jun 9, 2022 |
| 424B5 | Prospectus supplement | May 24, 2022 | — |
| 424B3 | Prospectus | May 24, 2022 | — |
| EFFECT | Filing | May 23, 2022 | — |
| UPLOAD | Letter from the SEC | May 19, 2022 | — |
| CORRESP | Letter to the SEC | May 19, 2022 | — |
| S-8 | Employee stock plan registration | May 16, 2022 | — |
| S-3 | Shelf registration | May 16, 2022 | — |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2022 | — |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 9, 2022 |
| 10-K | Annual report | Mar 30, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2022 | Mar 2, 2022 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs
|
Jan 4, 2022 | Jan 4, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 12, 2021 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Oct 26, 2021 | Oct 26, 2021 |
| 8-K |
Current report
Agreement ended
|
Aug 30, 2021 | Aug 27, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Other events
|
Jun 29, 2021 | Jun 29, 2021 |
| 8-K |
Current report
Results of operations
|
May 17, 2021 | May 17, 2021 |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2021 | Mar 30, 2021 |
| 10-K | Annual report | Mar 30, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Mar 10, 2021 | Mar 8, 2021 |
| S-8 | Employee stock plan registration | Feb 9, 2021 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Feb 9, 2021 | Feb 4, 2021 |
| 424B4 | Prospectus | Feb 5, 2021 | — |
| EFFECT | Filing | Feb 4, 2021 | — |
| CERT | Filing | Feb 4, 2021 | — |
| 8-A12B/A | Filing | Feb 4, 2021 | — |
| S-1/A | Amended registration statement | Feb 4, 2021 | — |
| CORRESP | Letter to the SEC | Feb 2, 2021 | — |
| CORRESP | Letter to the SEC | Feb 2, 2021 | — |
| 8-A12B | Filing | Feb 2, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 1, 2021 | — |
| S-1/A | Amended registration statement | Feb 1, 2021 | — |
| CORRESP | Letter to the SEC | Jan 26, 2021 | — |
| CORRESP | Letter to the SEC | Jan 15, 2021 | — |
| S-1 | Registration statement | Jan 15, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 18, 2020 | — |
| DRSLTR | Filing | Dec 15, 2020 | — |
| DRS/A | Filing | Dec 15, 2020 | — |
| D | Filing | Jun 23, 2020 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1601485
- Former names
- Angion Biomedica Corp. (until May 30, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.